Methionyl-tRNA synthetase inhibitor has potent in vivo activity in a novel Giardia lamblia luciferase murine infection model

BACKGROUND: Methionyl-tRNA synthetase (MetRS) inhibitors are under investigation for the treatment of intestinal infections caused by Giardia lamblia. OBJECTIVES: To properly analyse the therapeutic potential of the MetRS inhibitor 1717, experimental tools including a robust cell-based assay and a m...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Antimicrob Chemother
Prif Awduron: Michaels, Samantha A, Shih, Han-Wei, Zhang, Bailin, Navaluna, Edelmar D, Zhang, Zhongsheng, Ranade, Ranae M, Gillespie, J Robert, Merritt, Ethan A, Fan, Erkang, Buckner, Frederick S, Paredez, Alexander R, Ojo, Kayode K
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2020
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869794/
https://ncbi.nlm.nih.gov/pubmed/32011682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz567
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg